STOCK TITAN

TARS (NASDAQ: TARS) insider notifies sale of 4,440 shares via Fidelity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

Aziz A. Mottiwala files a Form 144 notifying a planned sale of 4,440 shares of Common Stock. The filing links the shares to restricted stock vesting dated 03/18/2026 and records two recent dispositions: 4,286 shares on 03/17/2026 and 4,330 shares on 03/18/2026.

The Form 144 names Fidelity Brokerage Services LLC as the broker-dealer. The filing characterizes the 4,440 shares as compensation-related restricted stock that vested on 03/18/2026.

Positive

  • None.

Negative

  • None.

Insights

Form 144 notifies a brokered resale of vested restricted shares by an insider.

The filing shows 4,440 shares tied to a restricted stock vesting event on 03/18/2026, with Fidelity Brokerage Services LLC listed as the broker-dealer. It also discloses recent dispositions of 4,286 and 4,330 shares on 03/17/2026 and 03/18/2026.

Timing and exact sale mechanics are governed by Rule 144 conditions; this notice signals an intent to sell but does not confirm execution details or proceeds. Subsequent SEC filings or broker confirmations will show completion.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does Aziz A. Mottiwala's Form 144 for TARS report?

It reports a planned sale of 4,440 shares of Common Stock tied to restricted stock vesting on 03/18/2026. The filing also lists broker-dealer Fidelity Brokerage Services LLC and two recent dispositions of 4,286 and 4,330 shares.

Are the 4,440 shares in the Form 144 newly vested or previously owned?

The Form 144 characterizes the shares as from a restricted stock vesting event on 03/18/2026, indicating they vested as compensation. The filing links the 4,440-share amount directly to that vesting date.

Which broker-dealer is handling the proposed TARS sale in the filing?

The filing names Fidelity Brokerage Services LLC (900 Salem Street, Smithfield, RI) as the broker-dealer. The document lists Fidelity in the securities-to-be-sold/broker section for the proposed transaction.

Did the filing disclose any recent sales by the same reporting person?

Yes, the filing shows two recent dispositions: 4,286 shares on 03/17/2026 and 4,330 shares on 03/18/2026. These are listed in the "Securities Sold During The Past 3 Months" section.

Does the Form 144 state sale proceeds or confirm the sale execution?

The Form 144 provides a notice of proposed sale under Rule 144 and lists planned quantities and broker-dealer, but it does not confirm execution details or proceeds. Completion and proceeds would appear in subsequent transactional records.
Tarsus Pharmaceuticals, Inc.

NASDAQ:TARS

View TARS Stock Overview

TARS Rankings

TARS Latest News

TARS Latest SEC Filings

TARS Stock Data

2.84B
40.38M
Biotechnology
Biological Products, (no Diagnostic Substances)
Link
United States
IRVINE